Navigation Links
More Breast cancer Cases Diagnosed In The UK

There has been an increase in the number of breast cancer cases in the UK. As many as 3,800 women were reported to have been diagnosed with the ductal carcinoma// in situ (DCIS) during 2002. The Cancer Research UK is engaged in finding out which of the hormone therapy drugs are capable of preventing the recurrence of the disease. The benefits derived from both tamoxifen and anastrozole are being studied. The DCIS is considered a pre-cancerous condition, which can later develop into invasive cancer.

The best therapy for the condition has not been decided upon as yet. Many women are not taking drugs which are capable of preventing the cancer from returning. Anastrozole is reported to be more effective than tamoxifen when it comes to reducing the recurrence of the disease, and the former is also capable of preventing the recurrence of 80% of these tumors. The DCIS trial has attracted as many as 20 nations across 42 centers in Britain. The breast screening programs are capable of detecting the DCIS. When the cells belonging to the breast’s milk ducts become cancerous, the condition is said to occur. As many as 10,000 women will be recruited by the Ibis-2 study, of whom about 4,000 have already been diagnosed with the DCIS.
'"/>




Page: 1

Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Breast cancer treatment to be determined by gene test
3. Breast Feeding prevents obesity later on in life
4. Breast milk is essential
5. Breast Cancer Surgery Causes Psychological problems
6. Breast cancer evidence
7. Letrozole Beats Tamoxifen in Breast Cancer Therapy
8. Breast screening among diabetic women
9. Breast feeding can alter hormones
10. Diet, Sunlight connected to Breast Cancer Risk
11. Additional Radiotheraphy for Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2017)... ... ... “The Land of More and More”: a brilliant story for children ... the simple and achievable answer. “The Land of More and More” is the creation ... in Angola, Indiana where he works with the children’s ministry department. , Michael ...
(Date:1/19/2017)... Los Angeles (PRWEB) , ... January 19, 2017 , ... ... Care Act will be repealed by Congressional political games that circumvent health needs of ... First Stand Rally” capture the human anxieties and needs government public servants were suppose ...
(Date:1/19/2017)... Ca (PRWEB) , ... January 19, 2017 , ... ... events for tech innovators, engineers, and scientists from around the world, announces the ... offers users a quick and easy portal to research breakthroughs and trending news, ...
(Date:1/19/2017)... ... January 19, 2017 , ... WholeHealth is announcing their participation ... Paziotopoulos, Andrew Petersen and Trish Henrie-Barrus will be present Saturday and Sunday in ... program. , “We know it’s easy to get carried away when you’re ...
(Date:1/19/2017)... ... January 19, 2017 , ... Bio-Optronics ... provides a modern CTMS workflow designed to seamlessly integrate and streamline the way ... to a single page, maximizing usability and improving efficiency significantly for users – ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 The U.S. Food and Drug Administration ... Constipation (CIC) in adult patients. "No one ... said Julie Beitz , M.D., director of the Office ... Evaluation and Research. "With the availability of new therapies, patients ... their condition." ...
(Date:1/19/2017)...  Stealth BioTherapeutics Inc. ( Stealth ), a clinical-stage ... announced new additions to its senior leadership team: ... and Daniel Geffken as interim Chief Financial ... , Pharm.D. has been promoted to Chief Clinical Development ... Doug and Daniel to our management team, as both ...
(Date:1/19/2017)... 19, 2017 James ... & Haematology, 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ... ... Published recently in a supplement to European ... touchONCOLOGY, an article by James Gilbart ...
Breaking Medicine Technology: